FACEFACTORY
LIVE

Serial Number

79316402

Owner

CUBIST CO., LTD.

Attorney

Sangwon Kim

Filing Date

Jun 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FACEFACTORY Trademark

Serial Number: 79316402 • Registration: 6938043

FACEFACTORY is a trademark filed by CUBIST CO., LTD. on June 15, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CUBIST CO., LTD. (3 trademarks)

(Nonhyeon-dong) 11, Eonju-ro 149-gil,

Entity Type: 03

Trademark Details

Filing Date

June 15, 2021

Registration Date

January 3, 2023

Published for Opposition

October 18, 2022

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 19, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 19, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 3, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Oct 17, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 28, 2022 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 28, 2022 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 24, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 3, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 29, 2021 REPR